Business news – Page 82
-
Business
EU warns DuPont and Honeywell over green refrigerants
Commission thinks cooperation may have been anti-competitive
-
Business
Amgen stacks up additional job cuts
Up to 1100 more staff face redundancy in ongoing restructuring plan
-
OpinionChemical space is big. Really big
You think it’s a long way to the back of your screening libraries? That’s peanuts to chemical space, says Derek Lowe
-
BusinessIneos bets big on shale
UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future
-
Business
Agilent to exit NMR
Closure of loss-making ex-Varian business gives users investment dilemma
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
BusinessEPA takes steps to prevent herbicide resistance in weeds
US Agency approves spray for resistant engineered crops, but with restrictions and time limit
-
Business
AbbVie backs out of Shire deal
Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits
-
BusinessIndian manufacturers hit back over quality claims
Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers
-
BusinessBio-based chemicals on the rise in US
Government predicts 10% of chemicals market will be renewable by 2015
-
Business
Endo outbids QLT for Auxilium merger
Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo
-
Business
Actavis boosts antibiotics with Durata buyout
$820 million deal gives Actavis control of newly-approved intravenous antibiotic
-
Business
US tax changes ripple into merger deals
Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
-
Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
-
Business
Becton Dickinson to buy CareFusion for $12bn
Medical devices merger continues consolidation trend
-
Business
Dow’s $1bn price-fixing fine upheld
Firm loses its appeal against damages for fixing polyurethane prices
-
Business
J&J to buy antiviral specialist Alios
$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
-
Business
Lumara splits and sells to AMAG and Perrigo
Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
-
Business
Mitsubishi to buy Japanese gases specialist
Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
-
FeatureTransparency measures forced on pharma
Previous misdemeanours are compelling the pharmaceutical industry to be more open with financial information and clinical data, writes Nuala Moran